Package 0187-5811-07

Brand: aplenzin

Generic: bupropion hydrobromide
NDC Package

Package Facts

Identity

Package NDC 0187-5811-07
Digits Only 0187581107
Product NDC 0187-5811
Product ID 0187-5811_45372e42-065d-4d87-89af-d5dcf09c29fb
Description

7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-07)

Marketing

Marketing Status
Marketed Since 2008-04-23
Brand aplenzin
Generic bupropion hydrobromide
Sample Package No

Linked Drug Pages (1)

Aplenzin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "45372e42-065d-4d87-89af-d5dcf09c29fb", "openfda": {"upc": ["0301875810306", "0301875811303"], "unii": ["E70G3G5863"], "rxcui": ["993550", "993552", "993567", "993569", "993681", "993683"], "spl_set_id": ["6494d2d9-0ce4-4126-b1c7-49684395942b"], "manufacturer_name": ["Bausch Health US, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-07)", "package_ndc": "0187-5811-07", "marketing_start_date": "20080423"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-30)", "package_ndc": "0187-5811-30", "marketing_start_date": "20080423"}], "brand_name": "Aplenzin", "product_id": "0187-5811_45372e42-065d-4d87-89af-d5dcf09c29fb", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0187-5811", "generic_name": "bupropion hydrobromide", "labeler_name": "Bausch Health US, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aplenzin", "active_ingredients": [{"name": "BUPROPION HYDROBROMIDE", "strength": "348 mg/1"}], "application_number": "NDA022108", "marketing_category": "NDA", "marketing_start_date": "20080423", "listing_expiration_date": "20271231"}